Stay updated with breaking news from Michael Benkowitz. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
United Therapeutics Corporation (NASDAQ:NASDAQ:UTHR) Q3 2022 Earnings Conference Call November 02, 2022 9:00 AM ET Company Participants Dewey Sedman – Head-Investor Relations Martine...
03.08.2022 - United Therapeutics Corporation (Nasdaq: UTHR), a public benefit corporation, today announced its financial results for the quarter ended June 30, 2022. Total revenues in the second quarter of 2022 grew 5% year-over-year to $466.9 million, compared ...
The FDA has approved Tyvaso DPI (treprostinil) for pulmonary arterial hypertension and pulmonary hypertension associated with interstitial lung disease to improve exercise ability.
United Therapeutics Corporation (NASDAQ:NASDAQ:UTHR) Q1 2022 Results Conference Call May 04, 2022 09:00 AM ET Company Participants Dewey Steadman - Head, IR Martine Rothblatt - Chairperson,...
Investegate announcements from Ferrer, Ferrer Announces Distribution Agreement With United Therapeutics for Treprostinil Inhalation Solution for Pulmonary Hypertension Associated With Interstitial Lung Disease